for the Better Assessment of Illness (BASIL) Study Group IMPORTANCE Measurement of delirium severity has been recognized as highly important for tracking prognosis, monitoring response to treatment, and estimating burden of care for patients both during and after hospitalization. Rather than simply rating delirium as present or absent, the ability to quantify its severity would enable development and monitoring of more effective treatment approaches for the condition.
D elirium is a common, serious, and often preventable complication among older adults. An estimated 12 million older US adults experience delirium each year, 1 atacostofover $164 billion in annual health care expenditures for 2011. 2 Delirium is distressing to patients and families, 3 prolongs hospital stays, delays rehabilitation, and increases risks for dementia and death. 1 Despite its importance for patient safety and public health, delirium is often unrecognized by clinicians, and effective treatments remain elusive. 1 Moreover, presentation of delirium is heterogeneous and multifaceted, and measurement of delirium and its severity pose unique challenges.
Advancing the measurement of delirium severity is important and provides a means to stratify risk, target treatment, and monitor for outcomes with instruments that already exist. Measurements of delirium severity should play an important role in the advancement of clinical care and research for persons with delirium. 4 Delirium severity ratings are associated with clinical outcomes and may serve as prognostic tools for clinical care. 4, 5 These instruments provide sensitive, continuous measures to track change and can provide finely grained information at the earliest onset of symptoms or response to treatment. Delirium severity instruments are useful to track clinical course and recovery, provide meaningful prognostic information, and help assess patient and caregiver needs after discharge. Severity measures can help to gauge the burden of clinical care, providing a means to identify safe staffing levels in the hospital or homecare setting, and provide data to evaluate the association of delirium severity with health care delivery and costs. 6 The recognition that more severe cases of delirium can lead to longterm cognitive decline 7 has indicated the importance of rapid recognition of more severe cases and the heightened need for tools to provide reliable serial monitoring during the entire course of delirium. These instruments may be used as outcome measures for clinical trials and prognostic studies and can advance statistical approaches and maximize the power of delirium studies. Delirium severity measures are also essential for studies of pathophysiology because determining the association of severity with biomarkers or other indicators may provide information about fundamental mechanisms of delirium. 6 At present, many measures of delirium severity are in active use and little is known about their comparative characteristics. Comparison of measures is particularly difficult because these instruments were created for different purposes (screening, diagnosis, and severity rating), targeted particular clinical settings and users, and captured different features or behaviors. [8] [9] [10] [11] [12] [13] [14] [15] [16] Although many systematic reviews of delirium instruments exist, [8] [9] [10] [11] [12] [13] [14] [15] [16] to our knowledge, none has focused specifically on delirium severity.
For this study, we defined delirium severity as the cumulative intensity of multidomain symptoms or behaviors associated with delirium and define delirium severity instruments as those capturing these symptoms or behaviors on a continuous, quantitative scale. Of 3 goals for this study, the first goal was to present a comprehensive review of delirium severity instruments identified from a systematic review of the literature from 1974 through 2017. The second goal was to evaluate the psychometric performance characteristics of the most commonly used delirium severity instruments, applying Consensus-based Standards for the Selection of Health Measurement Instruments (COSMIN) 17, 18 ratings to the instrument's original published report. The third goal was to select top-rated delirium severity instruments based on the frequency of use, COSMIN rating, evidence of construct and/or predictive validity, and breadth of coverage of symptom domains reflecting delirium severity.
Methods
The initial approach was informed by systematic literature review guidelines (PRISMA) 19 and specific recommendations for the evaluation of health outcome measures. 20 Our second stage review was conducted on the primary sources of research instruments (ie, the original published article) identified in the systematic review, followed by a quality review using the COSMIN framework. 17, 18 Finally, an expert panel of 7 interdisciplinary experts on delirium reviewed all evidence to select the top-rated instruments.
Systematic Literature Review
For the systematic review, we sought to identify comprehensively the measures used to operationalize delirium severity and to describe how delirium severity is defined and used in these studies. The search began with literature from 1974 because work on the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders (Third Edition) (DSM-III) was initiated that year, marking a major reconceptualization of the clinical features and definition of delirium. Our searches were updated twice and were inclusive through March 31, 2017.
Data Sources and Searches
We identified articles by pooling results of 2 comprehensive searches in 5 databases: CINAHL, Embase, PsycINFO, PubMed, and Web of Science. The first search focused on identification of articles with the keywords delirium and severity, and the second search focused on identifying articles with text keywords or subject headings relevant to delirium and tests or measures. Adding intensity to the search terms did not yield any additional instruments. Exclusion criteria were studies not focused on delirium or delirium severity, studies focused solely on alcohol withdrawal delirium, case reports or editorials, duplicates, studies involving children, conference abstracts, other article types (eg, nonclinical abstracts, unpublished dissertations, and books), studies not published in the English language, or studies for which full-text articles were unavailable. The flow diagram for selection of articles appears in Figure 1 . The specific search strategies used appear in eAppendix 1 in the Supplement. Identified articles underwent an initial screening based on title and abstract. The final eligibility determination was based on a review of the full text, followed by a data extraction phase detailed below.
Title and Abstract Initial Screening | This step was completed by 4 reviewers (including P.T., R.N.J., and S.C.) to identify duplicates and exclude manuscripts that did not meet criteria. Each article was first reviewed independently by 2 reviewers; the results were compared, and any discrepancies were resolved by consensus of all reviewers.
Full Text Review and Data Extraction | After the initial screening, full text was reviewed for final eligibility by a group of 8 reviewers (including A.A., B.H., J.Y., L.A.D., L.J.G., L.M., P.T., and R.N.J.). Each article was reviewed independently by 2 of the 8 reviewers. If either of the 2 reviewers rated the article as eligible, the article was included for data extraction. One of the reviewers (R.N.J., S.C., or any of the 8 reviewers) subsequently extracted information from eligible articles, including citation, study setting (intensive care unit, hospital service [medicine or surgery], rehabilitation, long-term care, residential care, community setting, emergency department, or other); sample size; name and citation for instruments used to measure delirium (up to 3); name and citation for other measures of cognition or behavioral symptoms; description of how delirium severity was defined; and specification of how delirium severity was used in the study (ie, outcome, main predictor, covariable, descriptor, or other). Our primary goal at this stage was to identify all potential instruments used to assess delirium severity.
To ensure comprehensive identification of studies and to avoid potentially biased selection based on requiring reporting in our specified electronic databases, we followed recommended approaches from the Institute of Medicine's standards for systematic reviews. 21 Thus, we augmented our electronic searches with hand reviews of reference lists in eligible studies, previously published reviews of delirium instruments, and queries to our expert panel to identify any delirium severity instruments that might have been missed.
COSMIN-Guided Methodologic Quality Assessment
Our second-stage review was focused on evaluating the methodologic quality of the initial published study for the selected delirium severity instruments. Rating only 1 validation study put each instrument on a similar level and minimized potential bias favoring earlier published instruments that were more likely to have multiple published validation studies. The original validation study of each instrument was selected; however, in 2 cases, instruments were later revised (Delirium Rating Scale-Revised-98 [DRS-R98] and Delirium Index) and the single later validation study was used. To be eligible, the instrument was required to use numeric ratings of delirium severity or intensity of delirium symptoms. Many studies defined delirium severity in terms of duration only (eg, days of delirium), without a numeric rating of symptom severity; these measures were excluded from the second stage review because measures of intensity have shown superior performance for prediction of clinical outcomes. 22 We used the COSMIN standards to rate the methodologic quality of measurement properties of the instruments as reported in the original published article for each instrument. Two of 6 reviewers (E.O., K.D., L.A.R., O.O., R.N.J., and S.C.) reviewed each manuscript independently and extracted and rated information according to the COSMIN framework. The COSMIN assessment items included ratings of the published descriptions of content validity, internal consistency, and construct, concurrent, and predictive validity of the instrument in the initial article. We also collected information on the intended sample for the instrument, educational level or professional certification suggested or required for the raters, length of the instrument (number of items), and time for administration. A third rater (R.N.J.) adjudicated the few minor discrepancies between the 2 independent COSMIN ratings of each article.
We summarized the quality of reporting asa0to6scale using an adaptation of the COSMIN scoring procedure described by Terwee et al. 23 Full scoring details for the 6 reliability and validity criteria are included in eAppendix 2 in the Supplement.
Expert Panel Ratings and Synthesis of Delirium Severity Instruments
We assembled a local interdisciplinary expert panel to review the results of the COSMIN-guided review of the 11 selected instruments and to select a recommended set of delirium severity instruments. The panel included experts from general internal medicine (E.R.M.), geriatric medicine (S.I. and T.H.), geriatric psychiatry (E.D.M.), cognitive neurology (T.G.F.), gerontological nursing (P.T.), and social work (E.M.S.). The panel met face-to-face 4 times in consensus sessions to adjudicate the instruments, with independent, blinded ranking assignments between meetings. All procedures followed a modified Delphi approach. 24 The panel agreed a priori on the following selection criteria for the instruments: (1) used in at least 2 or more articles in our systematic review to ensure use in at least 1 additional study beyond the original validation study; (2) a rating of 3.5 or higher on COSMIN criteria; (3) strong evidence of construct and/or predictive validity from the original validation study; and (4) broad domain coverage of 9 or more of 16 possible delirium symptom domains. The COSMIN rating of 3.5 or higher (of 6 criteria) was selected by the expert panel to exclude the lowest quality articles. In terms of domain representation, the cutpoint of 9 or more was selected because this is the minimum number needed to yield a scale reliability (McDonald ω) of 0.90 for a Rasch measurement model, which is considered as a minimum standard for patient-level outcome measures. 25 To assess domain coverage, 3 panel members were assigned to review independently the domain coverage of each instrument, and any results without complete agreement were adjudicated in 2 consensus conferences with all panel members. The expert panel had 2 additional consensus sessions to select the final top-rated instruments. At that time, there were no published head-to-head comparisons of any of the 11 instruments to our knowledge.
Results

Systematic Review and Identification of Studies Using Delirium Severity Measures
Results of the systematic review are presented in Figure 1 . We initially identified 9409 articles. After excluding studies not meeting our criteria, 228 articles remained and underwent full text review with data extraction.
Characteristics of the 228 manuscripts reviewed are presented in 
Selection of Delirium-Specific Severity Instruments
Of the 228 articles reviewed in full text, we identified 42 deliriumspecific instruments used for rating delirium and/or delirium severity (Table 1) . Most manuscripts (149; 65.4%) used more than 1 delirium instrument, of which some were not used to quantify severity. The identified instruments are presented in descending order of frequency in Table 2 . The 3 most commonly used instruments were the Confusion Assessment Method (CAM) 26 including the CAMSeverity score (CAM-S) (109; 47.8%), followed by the DRS including the DRS-Revised-98 (DRS-R98) 27 ,28 (101; 44.3%), and the Memorial Delirium Assessment Scale 29 (44; 19.3%). None of the remaining instruments were used in more than 5% of articles reviewed. Only 38 articles (16.7%) did not include any of the top 3 instruments. Excluded instruments (Table 2 ) included measures used for diagnosis or screening only (eg, Delirium Symptom Interview, Delirium Diagnostic Tool-Provisional, Delirium Detection Score, Nursing Delirium Screening Scale, and tachistoscope); measures that are single-item ratings of global severity (eg, Global Clinical Impression-Severity scale, Breitbart's Clinician's Global Rating for Delirium); measures that assessed a single domain or feature of delirium (eg, Richmond Agitation Sedation Scale, Riker Sedation-Agitation Scale, the Glasgow Coma Scale, Fainsinger consciousness score, Observational Scale of Level of Arousal, Delirium smartphone application, Bush Francis Catatonia Rating Scale, Delirium Motor Subtype Scale, and Delirium Motoric Checklist); measures rating distress not severity (eg, Delirium Experience Questionnaire); diagnostic criteria (eg, DSM and International Classification of Diseases); other measures that were not delirium specific (eg, Ease of Ward Management Scale and National Cancer Institute Common Terminology for Adverse Events); and measures that were only used in a single study in the systematic review (eg, 3-minute CAM-Severity scale [3DCAM-S], CAM for the intensive care unit-7 [CAM-ICU-7], Confusion Rating Scale, and Delirium Assessment Scale). Of note, the 3D-CAM-S 30 and CAM-ICU-7 6 were excluded at this stage because they did not include broad domain coverage across more than 9 domains and did not appear in more than 1 article in our systematic review.
COSMIN Methodologic Review of Delirium Severity Instruments
Of the 12 delirium-specific, multidomain instruments identified in the stage 1 review, 11 were included in the COSMIN review. The inclusion criteria for the COSMIN review were that the instrument provided a total score or summary rating of delirium features and was broadly inclusive of the multiple domains of delirium symptoms. Most of the articles (216; 94.7%) used 1 of the 11 identified instruments. The CAM-ICU was excluded at this stage because it did not provide a numerical rating of severity in the studies identified.
The most commonly used instrument across studies (Table 2 ) was the CAM. 26 Although the original instrument was not proposed as a multiple-domain quantitative summary of delirium severity, the more recent CAM-S 5 met the criteria and was included in the second stage COSMIN review. The Delirium Index, 31 another severity score derived from the CAM, was also included. Thus, COSMIN ratings were completed on 13 articles for 11 instruments. Two validation studies each were reviewed for the Delirium Index and revision 31, 32 and for the DRS and DRS-R98. 27 We included only the most recent validation study in each case in the final COSMIN adjudication. A summary of the results of the stage 2 COSMIN reviews is provided in the eTable in the Supplement.
The most common methodologic problem in the validation studies was inadequate sample size; 8 of the 11 manuscripts used small samples (n < 50) in at least 1 aspect of assessing reliability or validity. The most commonly missed COSMIN criteria were assessments of criteria or external validity (3 failed to report, 3 rated as fair, and 5 rated as good) and assessments of internal consistency reliability (1 failed to report, 6 rated as fair, and 4 rated as good). Only 1 study failed to report interrater reliability.
Expert Panel Ratings of Delirium Severity Instruments
Domain coverage of all instruments, as adjudicated by the expert panel, is shown in Figure 2 . The expert panel selected 6 final instruments ( Table 3 ) that met all selection criteria based on frequency of use (ie, 2 or more publications), methodologic quality (ie, COSMIN score of 3.5 or higher), strong evidence of construct or predictive validity, and broad domain coverage (ie, 9 or more domains). Table 3 includes logistic considerations (ie, time for completion and qualifications of raters), whether the instrument yields a delirium diagnosis by criteria (not by cutpoint alone, which provides for a dual-purpose instrument), as well as a numeric severity rating and details of the methodologic review (ie, COSMIN rating, construct and predictive validity, and domain coverage). The relative cost estimate provides a qualitative comparative estimate of the cost for application of each tool, as determined by a combination of the instrument administration time and required level of training and clinical experience of the rater. Two instruments, the Delirium-O-Meter and Delirium Observation Scale, had the shortest administration times (<5 minutes), whereas the DRS-R98 had the longest time (20-30 minutes). Only 2 instruments, the CAM-S and DRS-R98, provided delirium diagnosis by criteria. The Confusional State Examination and Delirium-O-Meter covered the broadest number of symptom domains (12 of 16 domains). Of the 6 instruments, the CAM-S was the only one originally designed to be rated by lay interviewers (and clinicians) and shown to have predictive validity for a range of clinical outcomes in the original study.
Discussion
Given the importance of delirium severity, identifying accurate and reliable approaches to measurement is crucial to advance the field and ultimately improve patient care. In our systematic review of 228 articles, we identified 6 delirium severity instruments that met prespecified criteria for frequency of use, methodologic quality, construct validity, and broad domain coverage. Each of these instruments represented an important contribution to the toolkit of delirium severity instruments. Overall, the CAM 26 (including the CAM-S 5 ), the DRS 33 (including DRS-R98 27 ), and the Memorial Delirium Assessment Scale 29 were the most commonly used instruments for delirium severity identified in our study; the 3 additional instruments were the Confusional State Examination, Delirium-OMeter, and Delirium Observation Scale. The selection of a specific delirium severity instrument for clinical or research purposes should be guided by the goals of use and logistical constraints. Each of the 6 instruments has unique strengths and limitations, and several potential scenarios for their use are provided here. For instance, for ratings of delirium severity reported by nurses during each work shift, the Delirium-O-Meter and Delirium Observation Scale provide brief (<5 minute) ratings requiring minimal training. However, although these ratings provide valuable information regarding trajectory and velocity of a patient's progress, they would require confirmation by experienced clinicians before a diagnosis of delirium can be established. Given its detailed ratings by skilled psychiatric-trained clinicians, the DRS has been widely used for phenomenological studies of delirium; however, the ratings can be time consuming (20-30 minutes) and may not be feasible for widespread clinical use. For studies requiring both a diagnosis of delirium and severity rating, the CAM-S might be preferred. The CAM-S can also be rated by nurses or trained lay interviewers, which may pose advantages for large-scale clinical studies or applications. For studies using the Mini-Mental State Examination, the Memorial Delirium Assessment Scale provides severity ratings based on MiniMental State Examination items. If broad domain coverage is a priority, particularly with inclusion of symptoms of behavioral or emotional dysregulation (eg, lability, anxiety, and depression), the Confusional State Examination or Delirium-O-Meter might be considered.
Although delirium severity measures have primarily been used in research to date, high-quality severity measures can have immediate, highly relevant applications in clinical care and qualityimprovement efforts. For example, patients identified with severe delirium should be prioritized for nonpharmacologic interventions to mitigate their symptoms and flagged for special follow-up monitoring because of their heightened risk for long-term cognitive decline. These patients are also likely to highly utilize health care and would benefit from case management or specialized pathways in current health care systems.
Strengths and Limitations
The strengths of the present study included the rigorous approaches applied to the comprehensive systematic review augmented by hand searches following Institute of Medicine guidelines, the methodologic rating based on the COSMIN approach, and rigorous expert panel processes for selection of the final top-rated instruments by prespecified criteria. The final result included 6 highquality, multidimensional, and flexible instruments to serve highly varied uses. This study was comprehensive and inclusive and served to demonstrate the wide spectrum of instruments in present use.
Several limitations deserve comment. First, one of the authors (S.I.) was the creator of the CAM-S, and several authors participated in its validation (E.S., E.M., and R.N.J.). Steps were taken to minimize potential bias throughout the process; for example, S.I. was not involved in the initial selection and COSMIN ratings and only involved in the final expert panel process. To further minimize bias, all interdisciplinary experts had equal votes in the final rankings and consensus was required on all decisions. Second, different search strategies or screening procedures may have identified different delirium severity instruments. However, we minimized this possibility by using the Institute of Medicine recommendations of hand reviews of bibliographies from articles and consultations with experts. Another potential limitation is that the COSMIN review was based on the original report only and using all published validation studies may have yielded differing results. However, allowing multiple validation studies favored earlier published instruments; thus, we chose to include only 1 article per instrument to place each instrument on a similar level. The COSMIN review rated only the quality of reporting, not the face or construct validity of the instruments. Thus, innovative and useful approaches to quantifying delirium severity might have been presented in publications that did not meet the rigorous reporting guidelines. An additional caveat was our choice to focus the COSMIN review on instruments assessing 9 or more domains. More lenient inclusion thresholds may have led to choosing instruments with fewer domains; however, our current threshold allowed us to achieve our goal of broad multidomain representation. All of the instruments identified required some verbal response from patients. Although some instruments can still be rated in nonverbal patients, the final list did not include any that were specific to the nonverbal patient, those with disturbed arousal, or in the intensive care unit setting. Standardizing scoring across instruments can be challenging and may require detailed scoring and training instructions. Future work will be needed to validate these instruments in persons with dementia. Finally, recently published instruments were at a disadvantage for inclusion because there was not an opportunity for the instrument to be used in 2 or more studies. This study may require updating as the field continues to evolve.
Conclusion
This study allowed us to more fully conceptualize delirium severity and to identify characteristics of an ideal instrument. These characteristics include an instrument that is quick to administer, is easy to use by raters with minimal training, yields diagnosis by criteria, and provides a severity rating, high construct and predictive validity, and broad domain coverage across delirium symptoms. Although this study did not allow us to identify a single best instrument and provide a recommendation for universal use, we identified 6 varied instruments with a broad range of clinical applications. The targeted uses of these instruments may strengthen and enable more consistent and accurate measurement of delirium severity to improve clinical outcomes of the condition and advance the science of delirium research. Future research may involve more head-tohead comparison studies of these instruments and pragmatic guidance to translate the studies into clinical practice. We reviewed the original publications of selected research instruments used for rating the severity of delirium. Data from the original publications were extracted by two different raters, and disagreement or discrepancy was resolved by a third rater. We focus on six aspects of measurement instrument validity defined within the COSMIN framework: content validity, effect indictors, internal consistency, construct validity, and external or criterionrelated validity (hypothesis testing in the COSMIN framework). These six elements are described in greater detail below. We ranked articles according to their coverage of each of six criteria by assigning articles a "1" to the criterion if it was addressed in the manuscript, otherwise a "0". We also incorporated sample size into the ratings as discussed below.
The six reliability and validity criteria considered were:
1. Content validity: describes the degree to which the content of the instrument is an adequate reflection of the construct to be measured. It is judged with respect to the description in the source article regarding the development of the content for the instrument. It is essential that measures adequately sample from the universe of signs or symptoms relevant to the construct that is being assessed. Measurement developers must be mindful of existing conceptual frameworks that describe the range of symptoms and characteristic signs of the construct and include relevant indicators in their measurement system. Articles were rated a 1 if the content derivation was described, otherwise 0. 2. Effect indicators: refers to the theoretical relationship between the items on the instrument and the underlying construct of delirium severity. In the context of delirium severity, effect indicators are caused by delirium, whereas in distinction causal indicators are putative causes of delirium. This is sometimes difficult to assess. Challenging symptoms include sleep disturbance, which can be viewed as a symptom of delirium or a putative cause of delirium. The importance of effect indicators is: if we considered a measure comprised of entirely cause or formative indicators, we would have a risk index rather than a summary of the severity of the underlying condition. Articles were rated a 0 if the item content included cause indicators, otherwise were rated 1. Justification is provided in the summary table. 3. Internal consistency: describes the degree of inter-relatedness among items. It is viewed as a measure of reliability in the COSMIN framework. 1 We awarded 1 point if inter-relatedness among items in the measure was evaluated, including via item-total correlations 2 and Cronbach's coefficient alpha 3 or more sophisticated methods such as McDonald's omega coefficient. 4 Internal consistency is considered important in measurement development to ensure that only one underlying construct is being assessed. Multidimensional concepts abound in health research, and delirium is certainly a multidimensional concept. Yet, multidimensional concepts pose challenges for measurement development and use. If we were to use the derived measure for capturing outcomes when evaluating an intervention trial, we would want to be sure that all aspects of the multiple dimensions were equally responsive to the intervention. On the other hand, if we were using the outcome measure to assess overall burden of illness severity, a multidimensional measure may be suitable. Ultimately, the practical importance of internal consistency depends on test use; however, because it is important for some uses, the reporting of internal consistency is a relevant quality criterion for the evaluation of medical tests. 4. Inter-rater reliability: refers to the extent to which ratings for patients are the same for simultaneous assessment by different raters. Because delirium is a fluctuating disease, inter-rater reliability is usually assessed with one interviewer (who also provides a rating) and one rater who observes but does not interact with patient or providers. Each rater completes their rating independently. 5. Construct validity: refers to the extent to which measures derived from the test correlate with other measures derived from other tests of the same or similar concept, or where subgroups of patients known to differ with respect to the concept so divergent scores. Evaluating construct validity is an important piece of evidence that provides quantitative support for the results of ensuring content validity. 6. External (or criterion-related) validity: refers to the extent to which measures derived from the test correlate with practical or clinically important outcomes. Prediction of important clinical outcomes or predictive validity is an important type of criterion validity. Tests of external validity amount to demonstrations of the practical utility of the proposed measure.
Final Scoring Instructions
As above, we examined six criteria thought to be important for rating delirium severity instruments: 1) content validity, 2) all effect indicators, 3) internal consistency reliability, 4) inter-rater reliability, 5) construct validity, and 6) external or criterion related validity. Each article received between 0 and 6 points, with 1 point for each of the six criteria if it was reported in the original publication. We deducted a half point if the criterion was addressed but was addressed with a small sample size. Terwee and colleagues 5 describe a four-category grading for sample size in reliability assessment: Excellent ratings are returned to studies that use an adequate sample size, described as at least 100 observations; Good ratings are for studies with between 50-99 observations; Fair ratings are for studies with moderate sample sizes (30-49 observations); and Poor ratings are for studies with sample sizes less than 30. We subtracted 1/2 point for studies with only partial reporting of the element or sample sizes in the fair or poor range (< 50 observations) for ratings of reliability (internal consistency, inter-rater) and validity (construct and criterion). For example, if a manuscript reported on internal consistency reliability with a coefficient alpha, but examined the statistic in a sample of less than 30, the manuscript would be assigned 1 point for examining internal consistency reliability, but lose ½ point for considering the statistic in a poor sample size, for net of +½ points for internal consistency. The specific scores of each article and points lost are displayed in the eTable 1 below.
eAppendix 3. Delirium Severity Systematic Review Study List
This list enumerates 228 articles identified via a systematic literature review that specifically focus on delirium severity and that were subject to full text review as described in Jones et al (2018, under 
